10-K: Ethema Health Corporation Faces Deepening Losses and Going Concern Doubts Despite Revenue Growth and Strategic Acquisitions

Ethema Health Corporation reported a significant increase in net losses for the fiscal year ended December 31, 2024, raising substantial doubt about its ability to continue as a going concern, despite a 12.6% revenue increase and strategic acquisitions.

Summary

• Ethema Health Corporation reported total revenue of $6,017,204 for the year ended December 31, 2024, an increase of 12.6% from $5,344,976 in 2023, primarily driven by a 16.5% increase in patient treatment revenue.
• The company's operating loss widened significantly to $1,333,129 in 2024, a 146% increase from an operating loss of $541,920 in 2023.
• Net loss before income taxes surged to $2,165,937 in 2024, compared to a net income of $614,453 in 2023, representing a 452.5% increase in loss.
• Total liabilities exceeded total assets by $7.5 million as of December 31, 2024, and the company reported an accumulated deficit of $44.4 million and a working capital deficiency of $9.1 million.
• The company acquired the remaining 25% interest in American Treatment Holdings, Inc. (ATHI) for $1,100,000 on May 15, 2024, and the assets of Boca Cove Detox, LLC for $240,000 (assets) plus $83,393 (security deposit assumption) on May 1, 2024.
• Subsequent to year-end, on January 9, 2025, Ethema's subsidiary ARIA Kentucky LLC acquired the addiction treatment operations of Edgewater Recovery Centers, LLC for $250,000 cash and assumed liabilities, with related party entities acquiring and leasing back the associated real properties.
• The company's common stock was downgraded to the OTC Pink Sheets market in January 2020 and traded at $0.0004 per share as of May 21, 2025.
• The Board of Directors approved amendments to the articles of incorporation on January 22, 2025, to increase authorized preferred stock to 30,000,000 shares and to effect a reverse stock split at a ratio between 1 for 1,000 and 1 for 5,000, at the board's discretion.
• Significant related party transactions occurred, including the conversion of $1,500,000 in payables to CEO Shawn Leon into 3,000,000,000 common shares and $500,000 in payables to his spouse Eileen Greene into 1,000,000,000 common shares.
• The company identified material weaknesses in its internal control over financial reporting, including insufficient written documentation of policies and procedures and limited segregation of duties due to resource constraints.

Sentiment

Score: 2

Explanation: The company is in severe financial distress, evidenced by significant and increasing losses, a substantial accumulated deficit, working capital deficiency, and a 'going concern' warning from both management and auditors. While revenue grew and strategic acquisitions were made, these were overshadowed by escalating operating expenses and a precarious financial position. The reliance on related party financing and identified internal control weaknesses further contribute to a highly negative outlook.

Positives

• Total revenue increased by 12.6% to $6,017,204 in 2024, driven by a 16.5% increase in patient treatment services.
• The increase in patient treatment revenue is attributed to organic growth in in-network patients and increased advertising spend.
• The company completed the acquisition of the remaining 25% of ATHI, consolidating full ownership of its primary operating subsidiary, Evernia Health Center LLC.
• Strategic expansion through the acquisition of Boca Cove Detox assets in 2024 and Edgewater Recovery Centers assets in January 2025, expanding its treatment facility footprint.
• Cash provided by financing activities significantly improved to $1.7 million in 2024, compared to cash used of $2.1 million in 2023.
• Cash used in operating activities decreased by 13.2% to $0.46 million in 2024.

Negatives

• Operating loss increased by 146% to $1,333,129 in 2024.
• Net loss before income taxes increased by 452.5% to $2,165,937 in 2024.
• Net loss increased by 315.2% to $2,165,937 in 2024.
• Operating expenses increased by 24.9% to $7,350,333, primarily due to higher general and administrative expenses (48.9% increase) and rent expense (112.1% increase).
• The company has an accumulated deficit of $44.4 million, a working capital deficiency of $9.1 million, and total liabilities exceeding total assets by $7.5 million as of December 31, 2024.
• The company's common stock was downgraded to the OTC Pink Sheets market in January 2020 and trades at a very low price of $0.0004 per share as of May 21, 2025.
• A convertible promissory note to Joshua Bauman is in technical default as of August 9, 2024, and remains outstanding.
• The company disposed of its rental income generating subsidiary, Cranberry Cove Holdings, resulting in a 100% decrease in rental revenue for 2024.

Risks

• The company's recurring operating losses, negative cash flow from operations, accumulated deficit, working capital deficiency, and total liabilities exceeding total assets raise substantial doubt about its ability to continue as a going concern.
• Management believes current available resources will not be sufficient to fund planned expenditures over the next 12 months, making the company dependent on raising additional capital.
• Future equity financing will result in significant dilution for existing stockholders, and debt financing may impose restrictive covenants.
• The company's stock is a 'penny stock,' which subjects it to SEC rules that may reduce trading activity and make it difficult for stockholders to sell their securities.
• The company derives approximately 100% of its in-patient revenues from a group of commercial healthcare insurers, making it highly vulnerable to adverse changes in their policies towards substance abuse treatment.
• Material weaknesses in internal control over financial reporting, including insufficient written documentation and limited segregation of duties, pose a risk of material misstatements not being prevented or detected.
• The company's ability to use its significant net operating loss carryforwards ($31.2 million federal, $2.3 million state) may be limited by IRC 382 if a cumulative change in ownership of more than 50% occurs within a three-year period.
• The personal guarantee by the Company President on the 950 Evernia Street lease exposes him to significant personal financial risk if certain financial and performance metrics are not met for its release after 5 years.

Future Outlook

Ethema Health Corporation anticipates requiring approximately $3.8 million in funding over the next twelve months to repay obligations other than convertible notes and for working capital to pursue additional addiction treatment opportunities in the US markets. Management acknowledges substantial doubt about the company's ability to continue as a going concern and states that current available resources will not be sufficient to fund planned expenditures. The company plans to raise additional capital through common shares and/or debt financing, which may lead to stockholder dilution or operational limitations through debt covenants. There is no assurance that future financing ventures will be successful.

Management Comments

• "Management believes that current available resources will not be sufficient to fund our planned expenditures over the next 12 months."
• "In the opinion of management, the Company’s liquidity risk is assessed as high."
• "Based on the uncertainties described above, we believe our business plan does not alleviate the existence of substantial doubt about our ability to continue as a going concern within one year from the date of the issuance of these consolidated financial statements."
• "Management constantly monitors the level of billings and collections on those billings and makes an estimation of the percentage of billings that will ultimately be recorded as revenue."
• "In the opinion of management, credit risk with respect to accounts receivable is assessed as low."
• "In the opinion of management, interest rate risk is assessed as moderate."
• "In the opinion of management, currency risk is assessed as low, immaterial and remains unchanged from that of the prior year."
• "In the opinion of management, the Company is not exposed to [other price] risk and remains unchanged from the prior year."

Industry Context

Ethema Health Corporation operates in the U.S. addiction treatment business, which functions as an insured healthcare service. The company's marketing efforts focus on establishing relationships with healthcare professionals and staff, with most clients sourced from in-network health care providers. The industry is highly competitive with a significant number of treatment facilities. The company's expansion into Boca Raton and Kentucky indicates a strategy of increasing its geographic footprint and patient capacity within this competitive landscape. The reliance on commercial healthcare insurers for 100% of in-patient revenue highlights a significant industry-specific concentration risk.

Comparison to Industry Standards

• The company's significant operating losses and net losses, coupled with a substantial accumulated deficit and working capital deficiency, indicate performance well below industry standards for a healthy, growing healthcare provider.
• The 'going concern' warning from management and auditors is a critical indicator of financial distress, which is not typical for well-established or rapidly expanding companies in the healthcare sector.
• The common stock trading at $0.0004 per share on the OTC Pink market suggests a very low market valuation and limited investor confidence, contrasting sharply with more stable, publicly traded healthcare companies.
• The high reliance on related party transactions for financing and asset transfers, including the conversion of significant payables into common and preferred shares, is unusual and often viewed negatively compared to standard corporate finance practices.
• The identified material weaknesses in internal controls, particularly regarding segregation of duties and documentation, fall short of best practices for public companies, especially those in a regulated industry like healthcare, where financial accuracy and compliance are paramount.

Corporate Governance

Legal Proceedings

• The company is not currently involved in any litigation that it believes could have a material adverse effect on its financial condition or results of operations.
• There are no pending or threatened actions, suits, proceedings, inquiries, or investigations that could have a material adverse effect on the company, its common stock, subsidiaries, or officers/directors.

Related Party Transactions

• Shawn E. Leon (CEO, CFO, President, Director) had a payable balance of $144,353 as of December 31, 2024. On July 12, 2024, he converted $1,500,000 of related party payables into 3,000,000,000 common shares. On September 27, 2024, he converted $6,000 of related party payables into 600,000 Series A Preferred stock.
• Eileen Greene (spouse of Shawn Leon) had related party payables of $488,965 and related party advances of $264,966 (net of unamortized debt discount) as of December 31, 2024. On July 12, 2024, she converted $500,000 of related party payables into 1,000,000,000 common shares. On July 4, 2024, she advanced the company $250,000 (with an original issue discount of $35,000, totaling $285,000), repayable in installments of $5,769.
• Leon Developments Ltd. (wholly owned by Shawn Leon) was owed $1,092,701 as of December 31, 2023, which was assigned to Shawn Leon in July 2024.
• Leonite Capital, LLC and Leonite Fund I, LLP (related parties due to prior investments) were involved in an exchange agreement on June 30, 2023, where the company exchanged Series B shares for its entire shareholding in Cranberry Cove Holdings. On August 4, 2023, the company repaid Leonite Capital $1,449,000 for outstanding loans.
• Shawn Leon personally guaranteed the long-term lease for the 950 Evernia Street property, which may be released after 5 years based on certain financial and performance metrics.
• Subsequent to year-end, BH Properties Fund LLC, a company controlled by Shawn Leon, acquired the real property associated with the Edgewater Recovery Centers acquisition and subsequently entered into lease agreements with Ethema's subsidiary ARIA Kentucky LLC on an arms-length basis.

Stakeholder Impact

• **Shareholders**: Face significant dilution from recent and potential future common stock issuances for debt conversion and capital raises. The proposed reverse stock split may not improve long-term value and could lead to further price volatility. The 'going concern' warning indicates a high risk of investment loss.
• **Employees**: The increase in salaries and wages, partly due to increased headcount and staffing for new facilities, suggests job stability or growth in the short term, but the company's financial instability poses a long-term risk to employment.
• **Customers (Patients)**: The expansion of treatment facilities (Boca Cove, Edgewater Recovery) suggests increased access to addiction treatment services. However, the company's financial struggles could impact service quality or continuity if not resolved.
• **Suppliers/Creditors**: The working capital deficiency and high liquidity risk indicate potential challenges in meeting short-term obligations. Creditors, especially those with unsecured or technically defaulted notes, face elevated risk.
• **Management**: Shawn E. Leon, as CEO, CFO, President, and a significant related party, is deeply intertwined with the company's financial health, including personal guarantees on leases and conversion of substantial personal payables into equity, indicating high personal exposure to the company's performance.

Next Steps

• The company will continue to seek additional opportunities for addiction treatment in the US markets.
• The company plans to raise additional capital through placement of common shares and/or debt financing to fund operations and business plans.
• Management intends to address material weaknesses in internal control over financial reporting, including establishing proper processes and systems, and potentially employing new qualified employees.
• The company will proceed with the approved amendments to its articles of incorporation, including the potential reverse stock split and increased authorized preferred stock.
• The newly acquired Boca Cove Detox facility is expected to generate revenue starting January 2025, and the Edgewater Recovery Centers acquisition is expected to contribute to future operations.

Key Dates

Recommendation

Keywords

Addiction Treatment, Healthcare Services, SEC Filing, 10-K, Financial Performance, Operating Loss, Net Loss, Going Concern, Liquidity Risk, Capital Raise, Related Party Transactions, Corporate Governance, Internal Controls, Substance Abuse Treatment, Florida Healthcare, Kentucky Healthcare, OTC Pink, Reverse Stock Split, Share Dilution